MAGnesium in Chronic HemoDialysis
Recruiting
- Conditions
- chronic kidney disease, end-stage renal disease<br /><br />chronische nierziekte, eindstadium nierfalen
- Registration Number
- NL-OMON23476
- Lead Sponsor
- VU University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 53
Inclusion Criteria
Age 18 years or above
- Hemodialysis with regular three times weekly dialysis schedule
Exclusion Criteria
- Intravenous magnesium supplementation (including total parenteral nutrition) in the last 2 weeks
- Expected cessation of dialysis treatment within three months after inclusion or expected permanent or temporary dialysis center switch to a center not participating in the trial within three months after inclusion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - The difference between plasma magnesium concentration after the long interdialytic interval in the intervention group with incremental dialysate magnesium concentration and plasma magnesium concentration in the control group with standard dialysate magnesium concentration at the end of week 8.<br /><br>- The difference in change of plasma magnesium concentration after the long interdialytic interval from baseline to the end of week 8 between the intervention group and the control group.<br>
- Secondary Outcome Measures
Name Time Method